ALL RESULTS
Showing 1-10 of 33 results
Sustainable Investing in Private Markets: Quiet Evolution, Not Death
While public commitments to environmental, social, and governance (ESG) have softened, sustainable investing in private markets is undergoing a strategic evolution rather than a retreat. Investors increasingly integrate material ESG...
Blogs
Healthcare PE in 1Q25: Defensive Postures, Selective Plays
Private equity (PE) activity in healthcare services hit a new low in 1Q25 as macroeconomic volatility and policy shocks disrupted deal flow. Yet amid the turbulence, investors are pivoting to...
Blogs
Tariffs Cloud IPO Outlook for US VC-Backed Startups
After a prolonged IPO drought, many venture-backed startups in the US were eagerly eyeing 2025 as a year to finally go public, but the most recent US tariffs have now...
Blogs
The Structural Reset in Real Estate Fundraising Amid Volatility
The global real estate fund market in 2024 was marked by cautious recalibration rather than a collapse. As allocators navigate macroeconomic headwinds and a tougher distribution environment, capital is consolidating...
Blogs
Tariffs and Turbulence: The Changing Flight Path of Aerospace & Defense
The aerospace and defense sector (A&D), long regarded as a pillar of economic and geopolitical stability, is now contending with an increasingly complex risk landscape. Escalating trade tensions, shifting fiscal...
Blogs
Policy Jitters and AI Boom Reshape Climate Tech VC Landscape
In 2024, climate tech startups found themselves under pressure, grappling with shrinking capital flows and intensifying investor scrutiny. Amid macroeconomic headwinds, AI-driven capital redirection, and mounting policy uncertainty, venture investors...
Blogs
Secondaries Cement Their Place with $160 Billion Record
Ardian’s landmark $30 billion raise for its secondaries fund in January 2025 marked a defining moment for private markets. It became the largest secondaries fundraise in history. The scale of...
Blogs
The AI Boom is Breathing New Life into Robotics Startups
A surge in artificial intelligence (AI) breakthroughs has reinvigorated investor excitement in robotics, driving significant venture capital (VC) into US robotics startups. The convergence of AI and advanced robotics is...
Blogs
Biopharma Modalities VC Trends: Selective Bets as Investors Seek De-Risked Opportunities
Biopharma modalities' venture capital (VC) investments are becoming more selective, favoring proven assets over high-risk innovation. While cardiometabolic drugs and AI-driven drug discovery continue to attract capital, investors are shifting...
Blogs